Deal Announcements

EyeCyte Nets Series A Funding Of $3 Million

Tuesday, June 24, 2008 5:39:00 AM PDT | VentureDeal Staff

ENCINITAS, CA -- Pharmaceutical research company EyeCyte (no web site) announced that it has received $3 million in its first round of institutional venture capital financing.

EyeCyte is a stem/progenitor cell ophthalmology research company developing treatments for retinal disease as discovered by Professor Martin Friedlander.

Pfizer Strategic Investments Group made the investment.  The financing will fund the company through 2010 and will drive product development for the company's first clinical target, diabetic retinopathy.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1